pyrazines has been researched along with Venous Thrombosis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Lemon, N; Rech, MA; Sterk, E | 1 |
| Chen, S; Ding, S; Xie, J | 1 |
| Anderson, KC; Bladé, J; Cavenagh, J; Esseltine, DL; Harousseau, JL; Jakubowiak, AJ; Lonial, S; Rajkumar, SV; Richardson, PG; San Miguel, J; Schuster, MW; Sonneveld, P | 1 |
| Camacho, FJ; Elrafei, T; Gucalp, R; Ho, L; Li, T; Perez-Soler, R; Piperdi, B; Rigas, JR | 1 |
| Gay, F; Palumbo, A | 1 |
| Andrade-Gordon, P; Ballentine, SK; Bone, RF; Brown, K; Crysler, CS; Damiano, BP; End, D; Giardino, EC; Lu, T; Markotan, T; Maryanoff, BE; Player, MR; Shukla, U; Spurlino, J; Tomczuk, BE | 1 |
| Dagher, NN; Locke, JE; Lonze, BE; Montgomery, RA; Segev, DL; Simpkins, CE; Singer, AL; Zachary, AA | 1 |
| Auwerda, JJ; Bertina, RM; de Maat, MP; Leebeek, FW; Osanto, S; Sonneveld, P; Yuana, Y | 1 |
| Fu, L; Jiang, F; Jin, Y; Liu, J; Liu, W; Zhang, Y | 1 |
| Diao, XJ; Gong, GQ; He, GW; Xu, YG; Yang, WH; Yang, XZ | 1 |
| Hsiao, G; Lee, YM; Sheu, JR; Yen, MH | 1 |
2 review(s) available for pyrazines and Venous Thrombosis
| Article | Year |
|---|---|
Efficacy and safety of the injection of the traditional Chinese medicine salviae miltiorrhizae and ligustrazine hydrochloride for the treatment of perioperative period of fracture: A meta-analysis of randomized controlled trials.
Topics: Blood Coagulation; Drugs, Chinese Herbal; Fractures, Bone; Humans; Perioperative Period; Phytotherapy; Pyrazines; Randomized Controlled Trials as Topic; Saliva; Treatment Outcome; Vasodilator Agents; Venous Thrombosis | 2020 |
How to treat elderly patients with multiple myeloma: combination of therapy or sequencing.
Topics: Acute Kidney Injury; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Combined Modality Therapy; Comorbidity; Disease Management; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Male; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Myeloablative Agonists; Peripheral Nervous System Diseases; Pyrazines; Randomized Controlled Trials as Topic; Remission Induction; Thalidomide; Transplantation Conditioning; Venous Thrombosis | 2009 |
3 trial(s) available for pyrazines and Venous Thrombosis
| Article | Year |
|---|---|
Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade) in chemotherapy-naïve patients with advanced stage non-small cell lung cancer (NSCLC).
Topics: Aged; Aged, 80 and over; Boronic Acids; Bortezomib; Carcinoma, Non-Small-Cell Lung; Disease Progression; Early Termination of Clinical Trials; Fatigue; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Protease Inhibitors; Pyrazines; Treatment Failure; Tumor Burden; Venous Thrombosis | 2010 |
Discovery and clinical evaluation of 1-{N-[2-(amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a thrombin inhibitor with an oxyguanidine P1 motif.
Topics: Amino Acid Motifs; Animals; Anticoagulants; Blood Pressure; Caco-2 Cells; Crystallography, X-Ray; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dogs; Double-Blind Method; Electrocardiography; Female; Fibrinolytic Agents; Guanidines; Guinea Pigs; Heart Rate; Hemodynamics; Humans; In Vitro Techniques; Male; Microsomes, Liver; Models, Molecular; Pyrazines; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Structure-Activity Relationship; Thrombin; Venous Thrombosis | 2010 |
Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Case-Control Studies; Cell-Derived Microparticles; Dexamethasone; Doxorubicin; Female; Humans; Male; Middle Aged; Multiple Myeloma; Pyrazines; Thalidomide; Thromboplastin; Venous Thrombosis; Vincristine | 2011 |
6 other study(ies) available for pyrazines and Venous Thrombosis
| Article | Year |
|---|---|
Acute venous thromboembolism after initiation of voxelotor for treatment of sickle cell disease.
Topics: Anemia, Sickle Cell; Benzaldehydes; Hemoglobin, Sickle; Humans; Pyrazines; Pyrazoles; Venous Thromboembolism; Venous Thrombosis | 2022 |
Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma.
Topics: Boronic Acids; Bortezomib; Clinical Trials as Topic; Dexamethasone; Drug Therapy, Combination; Erythropoietin; Female; Humans; Immunosuppressive Agents; Logistic Models; Male; Middle Aged; Multiple Myeloma; Protease Inhibitors; Pulmonary Embolism; Pyrazines; Recombinant Proteins; Recurrence; Risk; Treatment Outcome; Venous Thrombosis | 2008 |
Eculizumab, bortezomib and kidney paired donation facilitate transplantation of a highly sensitized patient without vascular access.
Topics: Adult; Antibodies; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD20; Boronic Acids; Bortezomib; Catheters, Indwelling; Creatinine; Desensitization, Immunologic; Drainage; Drug Therapy, Combination; Female; Femoral Vein; Humans; Iliac Vein; Immunoglobulins, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Plasmapheresis; Protease Inhibitors; Pyrazines; Splanchnic Circulation; Therapies, Investigational; Tissue and Organ Procurement; Vena Cava, Inferior; Vena Cava, Superior; Venous Thrombosis | 2010 |
Design, synthesis, and evaluation of 2-substituted ethenesulfonic acid ester derivatives as protein tyrosine phosphatase 1B inhibitors.
Topics: Adenosine Diphosphate; Animals; Benzimidazoles; Blood Platelets; Dabigatran; Drug Design; Esters; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Microsomes, Liver; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyrazines; Pyridines; Rabbits; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thrombin; Venous Thrombosis | 2012 |
Synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing a cleavable moiety with anti-platelet activity.
Topics: Adenosine Diphosphate; Animals; Benzimidazoles; Blood Platelets; Dabigatran; Drug Design; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Microsomes, Liver; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyrazines; Pyridines; Rabbits; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thrombin; Venous Thrombosis | 2012 |
Antithrombotic effects of tetramethylpyrazine in in vivo experiments.
Topics: Acute Disease; Adenosine Diphosphate; Animals; Aspirin; Bleeding Time; Blood Pressure; Drug Evaluation, Preclinical; Fibrinolytic Agents; Injections, Intravenous; Mesenteric Arteries; Mesenteric Veins; Mice; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Pyrazines; Radiation Injuries, Experimental; Reproducibility of Results; Thrombolytic Therapy; Vasodilator Agents; Venous Thrombosis | 2001 |